CN Patent

CN104163871A — 抗肿瘤的特异性剪接因子及制备方法

Assigned to Dalian Medical University · Expires 2014-11-26 · 11y expired

What this patent protects

本发明公开一种抗肿瘤的特异性剪接因子，以人类细胞cDNA为模板，以SEQ.ID.No3和SEQ.ID.No.4所示序列为引物，得到PCR产物A；以人类细胞cDNA为模板，SEQ.ID.No5和SEQ.ID.No.6所示序列为引物，得到PCR产物B；以人类细胞cDNA为模板，以SEQ.ID.No7和SEQ.ID.No.8所示序列为引物进行，得到PCR产物C；以人类细胞cDNA为模板，以SEQ.ID.No.9和SEQ.ID.No.10所示序列为引物进行，得到PCR产物D；PCR产物A与PCR产物B融合得到如SEQ.ID.No.1所示特异性剪接因子Ⅰ；PCR产…

USPTO Abstract

本发明公开一种抗肿瘤的特异性剪接因子，以人类细胞cDNA为模板，以SEQ.ID.No3和SEQ.ID.No.4所示序列为引物，得到PCR产物A；以人类细胞cDNA为模板，SEQ.ID.No5和SEQ.ID.No.6所示序列为引物，得到PCR产物B；以人类细胞cDNA为模板，以SEQ.ID.No7和SEQ.ID.No.8所示序列为引物进行，得到PCR产物C；以人类细胞cDNA为模板，以SEQ.ID.No.9和SEQ.ID.No.10所示序列为引物进行，得到PCR产物D；PCR产物A与PCR产物B融合得到如SEQ.ID.No.1所示特异性剪接因子Ⅰ；PCR产物C与PCR产物D相融合得到、如SEQ.ID.No.2所示特异性剪接因子Ⅱ。

Drugs covered by this patent

nusinersen-sodium (NUSINERSEN SODIUM)

Patent Metadata

Patent number: CN104163871A
Jurisdiction: CN
Classification: —
Expires: 2014-11-26
Drug substance claim: No
Drug product claim: No
Assignee: Dalian Medical University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.